| M | T | W | T | F | S | S | |
|---|---|---|---|---|---|---|---|
 | 1 | 2 | |||||
| 3 | 4 | 5 | 6 | 7 | 8 | 9 |
| 10 | 11 | 12 | 13 | 14 | 15 | 16 |
| 17 | 18 | 19 | 20 | 21 | 22 | 23 |
| 24 | 25 | 26 | 27 | 28 | 29 | 30 |
STIRLING PRODUCTS LIMITED (STI)
Stock Code: STI
Listing Date: 1997-07-24 00:00:00
Industry: Pharmaceuticals, Biotechnology & Life Sciences
Principal Activities:
Commercialising patented beta agonist Repartitioning Feed Enhancers ('RFEs') for livestock, which are being positioned as replacement products and alternatives to the use of antibiotics and hormones as growth promoters.
Address:
28 The Esplanade, BGC Centre, Level 11
PERTH
WA 6000
Phone: 08 9480 1480
Fax: 08 9226 4144
Executives & Directors
Prof. Clive P Page, Non Exec. Chairman, Non Exec. Director
Dr Calvin London, Managing Director
Mr Simon Robertson, Company Secretary
Company Podcasts
Subscribe to current and future audio events for this company by clicking on the podcast icon:
Company ASX Announcements
Company ASX announcements can be viewed on the ASX website.
Announcements from the preceding six months are shown below.
Click here to view this company's details on the ASX site
Company Events
STIRLING PRODUCTS LIMITED (STI)
| Amendment to Announcement Date Re Capital Raising | Fri, 21 Nov 2008 |
| RESULTS FROM ANNUAL GENERAL MEETING | Fri, 21 Nov 2008 |
| Capital Raising | Fri, 21 Nov 2008 |
| Stirling Consolidates Licensing Deals | Mon, 10 Nov 2008 |
| STIRLING GETS FIRST APPROVAL FOR OBESITY PATENT | Fri, 7 Nov 2008 |
| Appendix 4C Quarterly report | Fri, 31 Oct 2008 |
| Correction to Resolution 7 in the Notice of AGM | Thu, 30 Oct 2008 |
| Notice of Annual General Meeting/Proxy Form | Tue, 21 Oct 2008 |
| Annual Report to Shareholders | Tue, 21 Oct 2008 |
| Appendix 3Z - Final Directors Interest Notice | Tue, 14 Oct 2008 |
| STIRLING LAUNCHES PETQUENCH IN NORTH AMERICA | Wed, 1 Oct 2008 |
| CONSOLIDATION OF STIRLING NORTH AMERICAN OPERATION | Thu, 11 Sep 2008 |
| Appendix E - Preliminary Final Report | Fri, 29 Aug 2008 |
| STIRLING SIGNS FIRST PRODUCT FOR COMPANION ANIMALS | Thu, 14 Aug 2008 |
| AUDIO BROADCAST - SECOND QUARTER UPDATE | Thu, 7 Aug 2008 |
| RESIGNATION OF DIRECTOR | Thu, 7 Aug 2008 |
| Appendix 4C - quarterly | Wed, 30 Jul 2008 |
| STIRLING GETS AUSTRALIAN PATENT FOR HEAVES IN HORSES | Mon, 28 Jul 2008 |
| ProVale effective at inhibiting Loma infection in trout | Tue, 15 Jul 2008 |
| Stirling signs Term Sheet for novel insecticide | Mon, 16 Jun 2008 |
| Companion animal health initiative launching at BIO2008 | Fri, 13 Jun 2008 |
| Stirling Receives Performance Milestone for ProVale | Tue, 10 Jun 2008 |
| Stirling Products Signs up for Companion Animal Product | Wed, 4 Jun 2008 |
| Stirling North America Signs Supply Agreement for Provale | Fri, 30 May 2008 |
| Stirling Products` South African Registration Process | Wed, 28 May 2008 |
| Appendix 4C - quarterly | Wed, 30 Apr 2008 |
| Company Update | Tue, 22 Apr 2008 |
| STI-NA Starts Second Phase of Manufacturing Scale up | Wed, 26 Mar 2008 |
| SPNA offers Canadian Distribution for sale of Provale | Tue, 18 Mar 2008 |
| Stirling Signs Term Sheet for Diagnostic Device | Mon, 10 Mar 2008 |
| Licensing Rights for Omega-3 Meat Enhancement Technology | Thu, 6 Mar 2008 |
| Half Yearly Report and Accounts | Fri, 29 Feb 2008 |
| Change in substantial holding | Tue, 26 Feb 2008 |
| Stirling Announces Completion of Issue of Options | Fri, 22 Feb 2008 |
| Stirling signsTerm Sheet for Trialing ProVale in Chile | Tue, 5 Feb 2008 |
| Appendix 3B | Fri, 1 Feb 2008 |
| Appendix 4C - quarterly | Thu, 31 Jan 2008 |
| Stirling gets Registration Approval for Provale in Canada | Wed, 30 Jan 2008 |
| Change in substantial holding | Tue, 29 Jan 2008 |
| Allotment of Shares | Fri, 21 Dec 2007 |
| Second Material Transfer Agreement initiated | Wed, 12 Dec 2007 |
| First Phase of Manufacturing Scale-Up Completed | Wed, 5 Dec 2007 |
| Results of Meeting | Fri, 23 Nov 2007 |
| Chairman`s Address to Shareholders | Fri, 23 Nov 2007 |
| Expected Rapid Increase in Sales of Omega-3 Product | Tue, 20 Nov 2007 |
| Stirling Signs Distribution Agreement for Sale of ProVale | Mon, 12 Nov 2007 |
| Notice of Annual General Meeting/Proxy Form | Wed, 31 Oct 2007 |
| Annual Report to shareholders | Wed, 31 Oct 2007 |
| Improved Biological Activity of R-salbutamol Confirmed | Tue, 16 Oct 2007 |
| Audio Broadcast - Third Quarter Update | Mon, 15 Oct 2007 |
Please note: This company appears on this website as a result of its listing on the Australian Securities Exchange. Boardroom Radio does not claim any association with any company listed on this site.